Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Multiple Sclerosis Health Center

Font Size

New Details on Suspension of MS Drug Tysabri

3 Patients in Clinical Trials Developed Rare Disease; 2 Died
WebMD Health News

June 9, 2005 -- New information has surfaced about the rare but often lethal disease that prompted the removal of Tysabri, a new multiple sclerosis (MS) drug. At least three cases have been identified.

Tysabri was approved by the FDA last November. In late February, Tysabri's maker, Biogen Idec, voluntarily pulled it from the market. Tysabri's maker, Biogen Idec, voluntarily pulled it from the market. The suspension followed reports of one confirmed and one suspected case of progressive multifocal leukoencephalopathy (PML), a rare but often lethal viral disease of the central nervous system.

Now, three cases of PML have been confirmed; two of those were fatal. All three confirmed cases occurred in people who had taken Tysabri for more than two years in clinical trials. Two patients were also taking another MS drug called Avonex, according to reports in The New England Journal of Medicine's July 28 edition.

Possible 4th Case

There have also been media reports of a possible fourth case of PML. However, that "is still being reviewed and has not been confirmed," says FDA spokeswoman Lenore Gelb.

Gelb tells WebMD that Biogen Idec, a WebMD sponsor, notified the FDA of an adverse event experienced by a fourth patient who had been taking Tysabri and Avonex. FDA documents show that the patient was a 48-year-old woman, but it's not yet known if she had PML.

Biogen Idec spokeswoman Amy Brockelman says a newspaper headline last week incorrectly reported that the fourth patient was dead. The patient is not dead, and Biogen's safety evaluation of the drug is "ongoing," Brockelman tells WebMD.

Today on WebMD

nerve damage
Learn how this disease affects the nervous system.
woman applying lotion
Ideas on how to boost your mood and self-esteem.
woman pondering
Get personalized treatment options.
man with hand over eye
Be on the lookout for these symptoms.
brain scan
worried woman
neural fiber
white blood cells
sunlight in hands
marijuana plant
muscle spasm